Articles dans des revues avec comité de lecture (144)
  1. 9. Bellefroid, M., Rodari, A., Galais, M., Krijger, P., Tjalsma, S., Nestola, L., Plant, E., Vos, E., Cristinelli, S. S., Van Driessche, B., Vanhulle, C., Ait-Ammar, A., Burny, A., Ciuffi, A., De Laat, W., & Van Lint, C. (2022). Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization. Nucleic acids research, 50(6), 3190-3202. doi:10.1093/nar/gkac107
  2. 10. Rodari, A., Darcis, G., & Van Lint, C. (2021). The Current Status of Latency Reversing Agents for HIV-1 Remission. Annual review of virology, 8(1), 491-514. doi:10.1146/annurev-virology-091919-103029
  3. 11. Kula-Pacurar, A., Rodari, A., Darcis, G., & Van Lint, C. (2021). Shocking HIV-1 with immunomodulatory latency reversing agents. Seminars in immunology., 101478. doi:10.1016/j.smim.2021.101478
  4. 12. Hamann, M. M., Ehmele, P., Verdikt, R., Bialek-Waldmann, J. J., Virdi, S., Günther, T., Van Lint, C., Grundhoff, A., Hauber, J., & Lange, U. C. (2021). Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene. Virus research, 293, 198260. doi:10.1016/j.virusres.2020.198260
  5. 13. Kula-Pacurar, A., Rodari, A., Darcis, G., & Van Lint, C. (2021). Shocking HIV-1 with immunomodulatory latency reversing agents. Seminars in immunology, 51, 101478. doi:10.1016/j.smim.2021.101478
  6. 14. Verdikt, R., Hernalsteens, O., & Van Lint, C. (2021). Epigenetic mechanisms of hiv-1 persistence. Vaccines, 9(5), 514. doi:10.3390/vaccines9050514
  7. 15. Ait-Ammar, A., Bellefroid, M., Daouad, F., Martinelli, V., Van Assche, J., Wallet, C., Rodari, A., De Rovere, M., Fahrenkrog, B., Schwartz, C., Van Lint, C., Gautier, V., & Rohr, O. (2021). Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage (C. Van Lint, V. Gautier and O. Rohr are co-last authors). Scientific reports, 11(1), 2692. doi:10.1038/s41598-021-82164-w
  8. 16. Dutilleul, A., Rodari, A., & Van Lint, C. (2020). Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We Know. Viruses, 12(12). doi:10.3390/v12121385
  9. 17. Ait-Ammar, A., Kula, A., Darcis, G., Verdikt, R., De Wit, S., Gautier, V., Mallon, P., Marcello, A., Rohr, O., & Van Lint, C. (2020). Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. Frontiers in microbiology, 10, 3060. doi:10.3389/fmicb.2019.03060
  10. 18. Lange, U. C., Verdikt, R., Ait-Ammar, A., & Van Lint, C. (2020). Epigenetic crosstalk in chronic infection with HIV-1. Seminars in Immunopathology. doi:10.1007/s00281-020-00783-3
  11. 19. Darcis, G., Kootstra, N., Hooibrink, B., Van Montfort, T., Maurer, I., Groen, K., Jurriaans, S., Bakker, M., Van Lint, C., Berkhout, B., & Pasternak, A. (2020). CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency. Cell reports, 30(7), 2284-2296.e3. doi:10.1016/j.celrep.2020.01.071
  12. 20. Forouzanfar, F., Ali, S., Wallet, C., De Rovere, M., Ducloy, C., El Mekdad, H., El Maassarani, M., Aït-Ammar, A., Van Assche, J., Boutant, E., Daouad, F., Margottin-Goguet, F., Moog, C., Van Lint, C., Schwartz, C., & Rohr, O. (2019). HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing. Scientific reports, 9(1), 13154. doi:10.1038/s41598-019-48689-x
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>